Monochloroacetic acid versus cryotherapy or combination therapy in the treatment of warts: A Randomised Clinical Trial (WARTS-2)
Phase 4
Completed
- Conditions
- verrucae vulgariswarts1004743810014982
- Registration Number
- NL-OMON33146
- Lead Sponsor
- eids Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 400
Inclusion Criteria
All patients from the age of 4 onward, who present themselves to their practice with one or more new warts of the type verruca vulgaris on hands or feet will be included.
New warts are warts which are presented for the first time in their general practice by patients who have had no general practice (or dermatological) treatment for warts in the past year.
Exclusion Criteria
Immunocompromised patients
Patients with mosaic warts larger than 1 cm in diameter
Patients with warts who are pregnant or who are breastfeeding
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>*Cure', meaning all hand- or plantar wart(s) have totally disappeared (normal<br /><br>skin) at 13 weeks. </p><br>
- Secondary Outcome Measures
Name Time Method <p>The number of warts that still exist at follow-up, the subjective hindrance<br /><br>caused by the warts as well as by the treatment, pain and other adverse effects<br /><br>of the treatment, subjective judgement of the effect of the treatment by the<br /><br>patient, objective judgement of the effect of the treatment by the research<br /><br>nurse at follow up, referral to a dermatological department and the consumption<br /><br>of co-interventions during intervention period.</p><br>